Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...

Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services ...

The Department of Health and Human Services is re-evaluating a $590 million contract for avian influenza mRNA vaccines that ...

Under RFK Jr., HHS has canceled key vaccine meetings. Here's what that means for seasonal flu, bird flu, and childhood ...

American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...

As STAT’s Helen Branswell writes, mRNA vaccines are the fastest to make and the easiest to mass produce.

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

Highly pathogenic avian influenza A (H5) viruses were detected ... has died. For more, read: Moderna's stock stumbles on report HHS is reviewing $590 million award for bird-flu vaccine The CDC ...

The administration also told Vaxart Inc. to halt its research on an oral Covid vaccine, Bloomberg reports. In related news, the policy to cull poultry caught in H5N1 bird flu outbreaks will not be ...

The U.S. government awarded Moderna $590 million in January to ... of a pre-pandemic mRNA-based vaccine against the H5N1 avian influenza. "While it is crucial that the U.S. Department of Health ...